Functional Proteomics pp 79-93
Flow Cytometric Analysis of Cell Membrane Microparticles
Cell membrane microparticles (MPs) are phospholipid microvesicles shed from the plasma membrane of most eukaryotic cells undergoing activation or apoptosis. The presence of MPs is common in healthy individuals. However, an increase in their release is a controlled event and is considered a hallmark of cellular alteration. Microparticles display cell surface proteins that indicate their cellular origin. In addition, they may also express other markers, e.g., markers of cellular activation. Elevated levels of circulating MPs are associated with various vascular pathologies and their pathogenic potential has been widely documented. MPs have been analyzed in plasma and cell cultures by means of flow cytometry or solid phase assays. Here we present a three-color flow cytometric assay for immunophenotyping of MPs in plasma. This assay has been used to study elevated counts of different phenotypes of circulating endothelial MPs in several hematological and vascular diseases. A modified version of this assay can also be, used for MP analysis in blood products and cell cultures.
Key WordsCell membrane microparticles membrane microvesicles ectosomes flow cytometry monoclonal antibodies endothelial cells platelets vascular diseases
Unable to display preview. Download preview PDF.
- 11.Hugel, B., Martinez, M. C., Kunzelmann, C., and Freyssinet, J. M. (2005) Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20, 22–27.Google Scholar
- 17.Gelderman, M. P., Carter, L. B., and Simak, J. (2004) High counts of potentially pathogenic cell membrane microparticles in apheresis platelets. Blood 104, 988a.Google Scholar
- 20.Combes, V., Simon, A. C., Grau, G. E., Arnoux, D., Camoin, L., Sabatier, F., Mutin, M., Sanmarco, M., Sampol, J., and Dignat-George, F. (1999) In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest. 104, 93–102.PubMedCrossRefGoogle Scholar
- 21.Mallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J. M., and Tedgui, A. (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101, 841–843.PubMedGoogle Scholar
- 24.Jimenez, J. J., Jy, W., Mauro, L. M., Horstman, L. L., and Ahn, Y. S. (2001) Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br. J. Haematol. 112, 81–90.PubMedCrossRefGoogle Scholar
- 26.Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Croce, K., Furie, B. C., and Furie, B. (2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J. Exp. Med. 197, 1585–1598.PubMedCrossRefGoogle Scholar
- 28.Ogura, H., Tanaka, H., Koh, T., Fujita, K., Fujimi, S., Nakamori, Y., Hosotsubo, H., Kuwagata, Y., Shimazu, T., and Sugimoto, H. (2004) Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. J. Trauma 56, 823–830; discussion 830–831.PubMedCrossRefGoogle Scholar
- 31.Diamant, M., Nieuwland, R., Pablo, R. F., Sturk, A., Smit, J. W., and Radder, J. K. (2002) Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation. 106, 2442–2447.PubMedCrossRefGoogle Scholar